Kellogg’s donates additional funds to disaster relief efforts
BATTLE CREEK, Mich. — Kellogg’s has committed an additional $250,000 to disaster relief efforts in the Midwest and South, the company said.
The funds, which were donated from Kellogg’s Corporate Citizenship Fund to the American Red Cross, build on the company’s donation of $400,000 cash and its product commitment to hunger relief charity Feeding America to benefit disaster victims.
"We recognize the number and severity of natural disasters [are] stretching available resources for organizations aiding relief efforts," said Celeste Clark, SVP global public policy and external relations at Kellogg’s, and Kellogg’s Corporate Citizenship Fund president. "We are confident this donation will assist Red Cross with the critical services they are providing during this difficult time."
Molson Coors shuffles board executives
DENVER, Colo. — Molson Coors’ Andrew Molson and Pete Coors have switched roles.
The brewing company said that Molson, the company’s current vice chairman, has assumed the role of chairman, while Coors, its current chairman, has stepped in as vice chairman. The planned transition is consistent with the company’s by-laws, which allow the chairman and vice chairman to alternate between the Molson and Coors families every two years.
Molson has been a member of the Molson Coors board of directors since 2005. Coors is chairman of the board of MillerCoors, Molson Coors’ U.S. joint venture. He previously served as chairman of the board of Adolph Coors Co. from 2002 to 2005, and was CEO from May 2000 to July 2002. Coors also served as a director of Coors Brewing Co., the company’s U.S.-based subsidiary, beginning in 1973.
Gerber gets green light from FDA to tout health claim
FLORHAM PARK, N.J. — A milk formula for babies made by Gerber Products can reduce the risk of atopic dermatitis, and Gerber has the Food and Drug Administration’s permission to say so.
Gerber said Thursday that its Good Start milk-based formulas were the first and only infant formulas to meet the FDA’s criteria for a qualified health claim. The partially hydrolyzed formula may reduce a baby’s risk of developing atopic dermatitis in the first year.
“For healthy infants who are not exclusively breast-fed and who have a family history of allergy, feeding a 100% whey protein partially hydrolyzed infant formula from birth up to 4 months instead of a formula containing intact cow’s milk proteins may reduce the risk of developing atopic dermatitis throughout the first year of life,” the FDA’s official language read. “[The] FDA has concluded that the relationship between 100% whey protein partially hydrolyzed infant formulas and the reduced risk of atopic dermatitis is uncertain, because there is little scientific evidence for the relationship.”
Such groups as the American Academy of Pediatrics, the National Institute of Allergy and Infectious Diseases and the American Academy of Allergy Asthma and Immunology have said certain hydrolyzed protein infant formulas can reduce the risk of the condition, particularly in infants with a family history of allergy.